The European Society for Medical Oncology (ESMO) posted on LinkedIn:
“Are you working on cutting-edge research in cancer Drug Discovery or Targeted Therapies?
Submit your abstract for the ESMO TAT 2026 congress, taking place 16–18 March in Paris.
This is your opportunity to present your work to global leaders in oncology and shape the future of precision Cancer Treatment.
New this year: Trial in Progress (TiP) abstracts in all phases of clinical research may be submitted. Topics include New Drugs, biomarkers, trial design, AI, and more.
Deadline: 16 December 2025 Submit your abstract:
